select ad.sno,ad.journal,ad.title,ad.author_names,ad.abstract,ad.abstractlink,j.j_name,vi.* from articles_data ad left join journals j on j.journal=ad.journal left join vol_issues vi on vi.issue_id_en=ad.issue_id where ad.sno_en='52876' and ad.lang_id='3' and j.lang_id='3' and vi.lang_id='3'
ISSN: 2155-9880
Pietro Delise
In the clinical setting, drug testing is currently used to unmask a concealed Brugada Syndrome (BrS) both in patients with unexplained syncope and also in asymptomatic subjects with only suspect ECG signs. Recent studies, however, suggest that the induction of a Brugada type 1 ECG (Br type 1 ECG) by drugs may be an aspecific and/or a by-stander ECG sign. This is no idle hypothesis, as in clinical practice drug-induced Br type 1 ECG and BrS are often used as synonyms, feeding worldwide terror of this disease and resulting in an excess of inappropriate aggressive therapies in otherwise healthy subjects.
Condensed abstract: Drug testing is currently used to unmask a concealed Brugada Syndrome in patients with unexplained syncope and also in asymptomatic subjects with suspect ECG signs. Recent studies, however, suggest that the induction of a Brugada type 1 ECG by drugs may be an aspecific and/or a by-stander ECG sign.